维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="HOCHSTER HS"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma:Resulta ofan Eastern Cooperative Oncology Group study 显示文摘	Hochster HS Kim KM Green MD	1992	J Clin Oncol1992，10，：	1
2	Cancer stem cells: The promise and the potential 显示文摘	Ajani JA Song S Hochster HS	2015	Semin Oncol2015，421，：	1
3	Activity and Safety of vinorelbine combined with doxorubicin or fluorouracil as first-line therapy in advanced breast cancer:A stratified phaseⅡstudy显示文摘	Hochster HS Vogel CL Burman SL	2001	Oncologist2001，6，3：	1
4	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE study 显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
5	Newer approaches to gemcitabine-based therapy of pancreatic cancer: fixed-dose-rate infusion and novel agents显示文摘	Hochster HS	2003	Int J Radiat Oneol Biol Phys2003，56，4：	1
6	Maintenance Rituximab after CVP: results in superior clinical outcome in advanced follicular lymphoma (FL) : results of the E1496 phase Ⅲ trial from the Eastern Cooperative Oncology Group and the Cancer and Leukemia Group B 显示文摘	Hochster HS Weller E Gascoyne RD	2005	ASH Annual Meeting Abstracts2005，106，：	1
7	Phase Ⅰ study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma:results and and long-term follow-up- a report from the Eastern Cooperative Oncology Group 显示文摘	Hochster HS Oken MM Winter JN	2000	J Clin Oncol2000，18，5：	1
8	results of E1496:A phase Ⅲ trial of CVP with or without maintenance rituximab in advanced indolent lymphoma (NHL)显示文摘	HOCHSTER HS WELLER E RYAN T	2004	Proc Am Soc Clin Oncol2004，22，14：	1
9	Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer显示文摘	Hochster HS Hailer DG de Gramont A	2006	Cancer2006，107，4：	1
10	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastat- ic colorectal cancer: results of the TREE study显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin On- col2008，26，21：	1
11	4' Epidoxombicin ( epiru- bicin) : Activity in hepatocellular carcinoma 显示文摘	Hochster HS Green MD Speyer J	1985	J Clin Oncol1985，3，：	1
12	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE Study显示文摘	Hochster HS Hart LL Ramanathan RK		0，，21：	1
13	Oxaliplatin with weekly bolus fuorouracil and low-dose leucovorin as first line therapy for patients with advanced colorectal cancer显示文摘	Hochster HS Chachoua A Speyer J	2003	J Clin Oncol2003，21，14：	1
14	Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC) : Final analysis of the TREE-Study 显示文摘	Hochster HS Hart LL Ramanathan RK	2006	Proc Am Soc Clin Oncol2006，24，18：	1
15	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE Study显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
16	Activity and Safety of vinorelbine combined with doxorubicin or fluorouracil as first-line therapy in advanced breast cancer:A stratified phaseⅡstudy显示文摘	Hochster HS Vogel CL Burman SL	2001	Oncologist2001，6，3：	1
17	A phase I trial of oral ridaforolimus (AP23573 ; MK-8669) in com- bination with bevacizumab for patients with advanced can- cers显示文摘	Nemunaitis J Hochster HS Lustgarten S	2013	Clin Oncol (R Coil Radiol)2013，25，6：	1
18	Phase 1 study of fludarabine plus eyelophosphamide in previously untreated low - grade lymphoma: results and long - term follow - up - a report from the eastern cooperative Ontology Group 显示文摘	Hochster HS Oken MM Winter JN	2000	J Clin Oneol2000，18，5：	1
19	Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer( mCRC ) : Final analysis of the TREE-Study ( abstract3510 ) 显示文摘	Hochster HS Hart LL Ramanathan RK	2006	J Clin Oncol2006，24，18：	1
20	Consensus report of the international society of gastrointestinal oncology on therapeutic p rogress in advanced pancreatic cancer 显示文摘	Hochster HS HallerDG de GramontA	2006	Cancer2006，107，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示